IliAD Biotechnologies' Unattributed Round

IliAD Biotechnologies raised a round of funding on November 13, 2015.

ILiAD Biotechnologies (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. ILiAD's lead candidate is BPZE1, a live-atten…

Articles about IliAD Biotechnologies' Unattributed Round: